Literature DB >> 24575534

Colorectal cancer patients with oligometastatic liver disease: what is the optimal approach?

Martin R Weiser1, William R Jarnagin2, Leonard B Saltz2.   

Abstract

Although metastatic colorectal cancer is typically incurable, in a good percentage of patients (20% to 50%) who have oligometastatic disease confined to a single organ-usually the liver-complete metastasectomy can result in cure. However, once the decision to pursue surgery is made, there remain a number of issues that must be addressed in order to ensure the best possible outcome. These include whether to perform synchronous or staged resections of the liver metastasis and the primary colon cancer; whether surgery should be performed before, after, or in the absence of chemotherapy; if chemotherapy is used, which agents will be best; and in patients with locally advanced rectal cancer, whether pelvic radiation should be incorporated into the treatment plan. Unfortunately, there are limited data that can provide guidance in deciding these questions in a particular patient. Here we present the insights we have arrived at through our own considerable experience with this patient population, and we reflect on the relevant studies that are available.

Entities:  

Mesh:

Year:  2013        PMID: 24575534

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN: 0890-9091            Impact factor:   2.990


  14 in total

Review 1.  Management of oligometastatic rectal cancer: is liver first?

Authors:  Timur Mitin; C Kristian Enestvedt; Charles R Thomas
Journal:  J Gastrointest Oncol       Date:  2015-04

2.  SQ3370 Activates Cytotoxic Drug via Click Chemistry at Tumor and Elicits Sustained Responses in Injected & Non-injected Lesions.

Authors:  S Srinivasan; N A Yee; K Wu; M Zakharian; A Mahmoodi; M Royzen; J M Mejia Oneto
Journal:  Adv Ther (Weinh)       Date:  2021-01-20

3.  Totally laparoscopic simultaneous resection of colorectal cancer and synchronous liver metastases: a single-center case series.

Authors:  Arkaitz Perfecto; Mikel Gastaca; Mikel Prieto; Jorge Cervera; Patricia Ruiz; Alberto Ventoso; Ibone Palomares; José María García; Andrés Valdivieso
Journal:  Surg Endosc       Date:  2021-03-05       Impact factor: 4.584

4.  Early recurrence in patients undergoing curative resection of colorectal liver oligometastases: identification of its clinical characteristics, risk factors, and prognosis.

Authors:  Junzhong Lin; Jianhong Peng; Yixin Zhao; Baojia Luo; Yujie Zhao; Yuxiang Deng; Qiaoqi Sui; Yuanhong Gao; Zhifan Zeng; Zhenhai Lu; Zhizhong Pan
Journal:  J Cancer Res Clin Oncol       Date:  2017-11-11       Impact factor: 4.553

5.  Is there a survival benefit from adjuvant chemotherapy for patients with liver oligometastases from colorectal cancer after curative resection?

Authors:  Zhizhong Pan; Jianhong Peng; Junzhong Lin; Gong Chen; Xiaojun Wu; Zhenhai Lu; Yuxiang Deng; Yujie Zhao; Qiaoqi Sui; Desen Wan
Journal:  Cancer Commun (Lond)       Date:  2018-05-29

Review 6.  A Concise Review of Pelvic Radiation Therapy (RT) for Rectal Cancer with Synchronous Liver Metastases.

Authors:  Omer Sager; Ferrat Dincoglan; Selcuk Demiral; Bora Uysal; Hakan Gamsiz; Bahar Dirican; Murat Beyzadeoglu
Journal:  Int J Surg Oncol       Date:  2019-04-21

7.  BRAF V600E and SRC mutations as molecular markers for predicting prognosis and conversion surgery in Stage IV colorectal cancer.

Authors:  Yoshifumi Shimada; Yusuke Muneoka; Masayuki Nagahashi; Hiroshi Ichikawa; Yosuke Tajima; Yuki Hirose; Takuya Ando; Masato Nakano; Jun Sakata; Hitoshi Kameyama; Yasumasa Takii; Yiwei Ling; Shujiro Okuda; Kazuaki Takabe; Toshifumi Wakai
Journal:  Sci Rep       Date:  2019-02-21       Impact factor: 4.379

8.  Sleeping beauty genetic screen identifies miR-23b::BTBD7 gene interaction as crucial for colorectal cancer metastasis.

Authors:  Eleonora Grisard; Michela Coan; Laura Cesaratto; Ilenia Rigo; Luigi Zandonà; Alice Paulitti; Eva Andreuzzi; Gian Luca Rampioni Vinciguerra; Evelina Poletto; Fabio Del Ben; Giulia Brisotto; Eva Biscontin; Matteo Turetta; Erik Dassi; Alex Mirnezami; Vincenzo Canzonieri; Andrea Vecchione; Gustavo Baldassarre; Maurizio Mongiat; Riccardo Spizzo; Milena S Nicoloso
Journal:  EBioMedicine       Date:  2019-07-11       Impact factor: 8.143

9.  Preoperative AFU Is a Useful Serological Prognostic Predictor for Colorectal Liver Oligometastasis Patients Undergoing Hepatic Resection.

Authors:  Yuxiang Deng; Yujie Zhao; Wenhua Fan; Jianhong Peng; Xiao Luo; Yiwen Mo; Binyi Xiao; Lin Zhang; Zhizhong Pan
Journal:  J Cancer       Date:  2019-08-28       Impact factor: 4.207

10.  Clinical impact of PET/MRI in oligometastatic colorectal cancer.

Authors:  Felipe S Furtado; Krista E Suarez-Weiss; Mark Vangel; Jeffrey W Clark; James C Cusack; Theodore Hong; Lawrence Blaszkowsky; Jennifer Wo; Robin Striar; Lale Umutlu; Heike E Daldrup-Link; David Groshar; Ricciardi Rocco; Liliana Bordeianou; Mark A Anderson; Amirkasra Mojtahed; Motaz Qadan; Cristina Ferrone; Onofrio A Catalano
Journal:  Br J Cancer       Date:  2021-07-19       Impact factor: 9.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.